New hope for advanced cancer: VIB305 trial opens for patients out of options
Disease control
Recruiting now
This study tests an experimental drug, VIB305, in people with advanced solid tumors that have not responded to or cannot be treated with standard therapies. The trial has two parts: first, finding the safest dose, and then testing that dose in more patients to see if it shrinks t…
Phase: PHASE1, PHASE2 • Sponsor: Vibrant Sciences Limited • Aim: Disease control
Last updated May 05, 2026 11:54 UTC